missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Integrin alpha L beta 2 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marke: R&D Systems™ 3868-AV-050
464.78 EUR gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
The Recombinant Human Integrin alpha L beta 2 Protein is derived from CHO. The Recombinant Human Integrin alpha L beta 2 Protein has been validated for the following applications: Bioactivity.Spezifikation
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 121.7 kDa (Integrin alphaL), 79 kDa (Integrin beta2) | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 3683 | |
| Integrin alpha L beta 2 | |
| Chinese Hamster Ovary cell line,CHO-derived human Integrin alpha L beta 2 protein, (N-terminus) Human Integrin alpha L (Tyr26-Met1089) Accession &Num; P20701 acidic tail Human Integrin beta 2 (Gln23-Asn700) Accession &Num; P05107 basic tail (C-terminus) | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |